Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Aug 08, 2017 1:36pm
87 Views
Post# 26557068

RE:RE:RE:RE:RE:RE:Well this is just as impressive !

RE:RE:RE:RE:RE:RE:Well this is just as impressive !
bionicjoe wrote:
fredgoodwinson wrote: A strange interpretetion of my post.It is never the case that a stock can only go up but there is a difference between taking a calculated risk based upon due diligence and being so timid as to taking on any risk at all that by the time you dip a toe in the water it will cost you an arm and a leg. This stock appears to be far too risky for your comfort and you might re-consider whether you are equipped to provide balanced advice to posters here - none of whom are asking for it anyway.


Given the overwhelmingly vast preponderance of retail investors who got their toes chopped off and much more by blindly staying long a stock, you must excuse those who would like to see a little more certainty before committing their life savings to what is still an experiment in progress. I've yet to hear from HC or the FDA so I'll reserve judgment on whether any cure for cancer has yet been found. What you call timid others might see as wise investing.


Committing your life savings to one stock is what you call wise investing?
No one here needs your investment advice.
Early bird investors who are comfortable with early biotech opportunities on the venture and want to take a small to modest position as the company gets derisked is who would like to come here and discuss the POTENTIAL of the company and market valuation, not have to listen to you all day.
If you're not comfortable with the risk or speed of progress, please sell your shares, if you have any and move on.
Bullboard Posts